Evidence map›Paper›PMID 35677762›Full record

ArticleFrontiers in public health2022

Development and Validation of a Risk Stratification Model of Pulmonary Ground-Glass Nodules Based on Complementary Lung-RADS 1.1 and Deep Learning Scores.

Qingcheng Meng, Bing Li, Pengrui Gao, Wentao Liu, Peijin Zhou, Jia Ding, Jiaqi Zhang, Hong Ge

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Risk prediction for lung cancer screening: a systematic review and meta-regression.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qingcheng MengDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Bing LiDepartment of Radiotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Pengrui GaoDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Wentao LiuDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Peijin ZhouDepartment of Radiology, The People's Hospital of Nanzhao Country, Nanyang, China.
Jia DingYizhun Medical AI Co. Ltd, Beijing, China.
Jiaqi ZhangYizhun Medical AI Co. Ltd, Beijing, China.
Hong GeDepartment of Radiotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the value of novel deep learning (DL) scores combined with complementary lung imaging reporting and data system 1.1 (cLung-RADS 1.1) in managing the risk stratification of ground-glass nodules (GGNs) and therefore improving the efficiency of lung cancer (LC) screening in China. Materials and Methods: Overall, 506 patients with 561 GGNs on routine computed tomography images, obtained between January 2017 and March 2021, were enrolled in this single-center, retrospective Chinese study. Moreover, the cLung-RADS 1.1 was previously validated, and the DL algorithms were based on a multi-stage, three-dimensional DL-based convolutional neural network. Therefore, the DL-based cLung-RADS 1.1 model was created using a combination of the risk scores of DL and category of cLung-RADS 1.1. The recall rate, precision, accuracy, per-class F1 score, weighted average F1 score (F1 Results: The percentage of neoplastic lesions appeared as GGNs in our study was 95.72% (537/561) after long-period follow-up.Compared to cLung-RADS 1.1 model or DL model, The DL-based cLung-RADS 1.1 model achieved the excellent performance with F1 scores of 95.96% and 95.58%, F1 Conclusion: The DL-based cLung-RADS 1.1 model shows the best performance in risk stratification management of GGNs, which demonstrates substantial promise for developing a more effective personalized lung neoplasm management paradigm for LC screening in China.

Indexed as

Deep LearningLung NeoplasmsMultiple Pulmonary NodulesHumansLungRetrospective StudiesRisk AssessmentTomography, X-Ray Computedconvolutional neural networklung imaging reporting and data systemlung neoplasmsrisk stratificationX-ray computed tomography

Identifiers

PMID35677762
PMCPMC9168898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.